Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 September 2021 | Story Nonsindiso Qwabe
“This way please” UFS Clinic nurses point the way. From left to right: Sister Nangamso Lukhubeni, Sister Noluthando Luthuli, Sister Mathapelo Moloi, and Sister Modiehi Moloi.

Fully vaccinated! 

These were the words uttered by many Qwaqwa staff members who received their second Pfizer jab at the vaccination site on the Qwaqwa Campus on Thursday (2 September 2021). More than 100 staff members turned up at the site, many for the second jab, while others were there to get their first. The staff members were full of praise for the convenience of having a site on campus, and said the brisk service made the entire process a breeze. The 24/7 Study Centre on campus was repurposed as a vaccination site at the end of August, bringing much-needed relief to staff and students, as well as the Qwaqwa community.

The vaccination experience

Chelly König, Professional Officer in the Department of Chemistry, urged people to trust the science behind the vaccine and the fact that it works. König also came with her relatives. “I’m fully vaccinated and feeling fantastic. I’d urge anyone who’s still hesitant to trust the sciences; these people know what they are doing. My aunt, who is 62, developed COVID-19 after getting her two jabs, and she didn’t experience any effects at all. It was just like the flu. Seeing her recovery convinced me that the vaccine works.”

Ntswaki Mokoena of Bidvest Prestige Cleaning Services also received her second jab. She said: “I am fully vaccinated and so happy. I’ve experienced no side effects whatsoever, and I encourage people to vaccinate; the vaccine is harmless. They should not listen to naysayers who haven’t even vaccinated.”

Calling on more people to vaccinate 

Sister Mathapelo Moloi, Chief Officer at the campus clinic, said the vaccination drive was a source of pride for the campus. “Our priority is to re-open the campus, so I’m very happy that we are seeing staff and students being willing to get vaccinated.”

“It’s not the first time that there has been hesitancy around the vaccine. Providing information is our priority – to help them understand the side effects and everything pertaining to the vaccine.”

Acting Director of Student Affairs on Qwaqwa Campus, Zakhele Mdluli, said vaccinations would help the university community get back to normal. “I encourage students to get vaccinated so that they are able to come back to campus knowing that everyone is safe. This vaccination is no different from the vaccinations we used to get when we were younger.”

The centre operates Monday to Friday from 08:00 to 15:00. People can pre-register either online at https://vaccine.enroll.health.gov.za or via WhatsApp on +27 0 60 012 3456 and should bring along their identity documents. The site is open to anyone 18 years and older. They can simply walk in – no bookings are required.”

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept